Healthcare -
Biotechnology - NASDAQ - US
$ 3.35
0.601 %
$ 2.33 M
Market Cap
0.0
P/E
RNAZ - CASH & EQUIVALENTS
Cash & Equivalents RNAZ - TransCode Therapeutics, Inc.
2.77 M
LAST VALUE
-63.55%
2 YEAR CAGR
67.01%
5 YEAR CAGR
0.00%
10 YEAR CAGR